Abstract
Condition: Multiple Sclerosis
Intervention: Drug: Mavenclad®
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Not yet recruiting
ID: 7
Discovery Date: 08 March 2021, 12:17:02 UTC
Published Date: 2021-03-05 17:00:00
Source: Clinical Trials.gov
Link: https://clinicaltrials.gov/ct2/show/NCT04783935?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14